Trials / Conditions / Pneumococcal Infection

Pneumococcal Infection

31 registered clinical trials studyying Pneumococcal Infection — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002) NCT07300267	Merck Sharp & Dohme LLC	Phase 1
Not Yet Recruiting	Opportunistic Pneumococcal Immunisation Trial in MALnutrition NCT06817421	Nick Fancourt	Phase 4
Completed	A Clinical Study of the V116 Vaccine for Children and Teenagers (V116-013) NCT06177912	Merck Sharp & Dohme LLC	Phase 3
Completed	Safety and Immunogenicity of V116 in Adults With Increased Risk for Pneumococcal Disease (V116-008) NCT05696080	Merck Sharp & Dohme LLC	Phase 3
Completed	Safety and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults (V116-003, STRIDE-3) NCT05425732	Merck Sharp & Dohme LLC	Phase 3
Completed	Safety, Tolerability, and Immunogenicity of V110 or V114 Co-administered With a Booster Dose of mRNA-1273 in H NCT05158140	Merck Sharp & Dohme LLC	Phase 3
Completed	Safety, Tolerability, and Immunogenicity of a Polyvalent Pneumococcal Conjugate Vaccine (V116) in Japanese Adu NCT04665050	Merck Sharp & Dohme LLC	Phase 1
Completed	The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines on Immunogenicity and Carriage in Kenyan Inf NCT03489018	London School of Hygiene and Tropical Medicine	Phase 4
Unknown	A Study to Evaluate the Safety and Immunogeneicity of Multivalent Pneumococcal Conjugate Vaccine in Healthy Ad NCT03549208	LG Chem	Phase 1
Completed	Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents NCT03619252	Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology	Phase 4
Completed	A Study to Evaluate the Safety and Immunogenecity of LBVE(Multivalent Pneumococcal Conjugate Vaccine) in Healt NCT03467984	LG Chem	Phase 2
Unknown	Mobile Phone SMS Messages and Automated Calls in Improving Vaccine Coverage Among Children in Pakistan NCT03341195	Aga Khan University	N/A
Completed	A Phase I Study to Evaluate the Safety and Immunogenicity of PnuBioVax NCT02572635	ImmunoBiology Limited	Phase 1
Completed	Residual Anti-pneumococcal Immunity After Pneumococcal Immunization in ANCA-associated Vasculitis NCT02463539	Assistance Publique - Hôpitaux de Paris	—
Unknown	Immunogenicity of a Combined Anti-pneumococcal Vaccine Schedule in Patients With ANCA-associated Vasculitis NCT02463578	Assistance Publique - Hôpitaux de Paris	—
Completed	Open Randomized Trial Evaluating Four Anti-pneumococcal Vaccine Strategies With Fractionated Doses of Non Conj NCT02279589	Assistance Publique - Hôpitaux de Paris	Phase 2
Completed	Revaccination With PNEUMOVAX™ 23 in Older Japanese Adults (V110-902) NCT02260882	Merck Sharp & Dohme LLC	Phase 4
Completed	Systems Biology of PNEUMOVAX®23 and PREVNAR 13® NCT01307449	Emory University	N/A
Completed	Study of Evaluating Safety and Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine With Influenza NCT02062281	Jiangsu Province Centers for Disease Control and Prevention	Phase 4
Completed	Pneumococcal Vaccination for Splenectomised Thalassemia Major Patients in Indonesia NCT03095326	Fakultas Kedokteran Universitas Indonesia	Phase 4
Terminated	Aerosolized and Intravenous Colistin in Healthy Adults NCT01863719	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1
Completed	Pneumonia Vaccine in Aging HIV Positive Individuals NCT02558751	University of Toledo Health Science Campus	EARLY_Phase 1
Completed	A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 7 NCT01654263	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2
Completed	A Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) In Healthy Infants In China NCT01692886	Pfizer	Phase 3
Completed	A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Subjects NCT01531322	Pfizer	Phase 1
Completed	Immune Response to Pneumococcal Vaccination in HIV Infected Individuals NCT02515240	University of Toledo Health Science Campus	EARLY_Phase 1
Unknown	A Retrospective Epidemiological Study on Pneumococcal Infection in Children in Ministry of Health Hospital at NCT00844467	King Saud University	—
Completed	Revaccination With PNEUMOVAX(TM) 23 in Older Adults (V110-007) NCT00560950	Merck Sharp & Dohme LLC	Phase 3
Completed	ZOSTAVAX™ Administered Concomitantly With PNEUMOVAX™ 23 (V211-012)(COMPLETED) NCT00535730	Merck Sharp & Dohme LLC	Phase 3
Completed	Safety, Tolerability and Immunogenicity of Pneumovax 23 in Healthy Adults in India (V110-011) NCT00496093	Merck Sharp & Dohme LLC	Phase 3
Completed	9-valent CRM 197 Pneumococcal NCT00133549	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2